HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Associations between markers of cellular and humoral immunity to rubella virus following a third dose of measles-mumps-rubella vaccine.

AbstractINTRODUCTION:
Rubella virus (RV) was eliminated in the United States in 2004, although a small portion of the population fails to develop long-term immunity against RV even after two doses of the measles-mumps-rubella (MMR) vaccine. We hypothesized that inherent biological differences in cytokine and chemokine signaling likely govern an individual's response to a third dose of the vaccine.
METHODS:
Healthy young women (n = 97) were selected as study participants if they had either low or high extremes of RV-specific antibody titer after two previous doses of MMR vaccine. We measured cytokine and chemokine secretion from RV-stimulated PBMCs before and 28 days after they received a third dose of MMR vaccine and assessed correlations with humoral immune response outcomes.
RESULTS:
High and low antibody vaccine responders exhibited a strong pro-inflammatory cellular response, with an underlying Th1-associated signature (IL-2, IFN-γ, MIP-1β, IP-10) and suppressed production of most Th2-associated cytokines (IL-4, IL-10, IL-13). IL-10 and IL-4 exhibited significant negative associations with neutralizing antibody titers and memory B cell ELISpot responses among low vaccine responders.
CONCLUSION:
IL-4 and IL-10 signaling pathways may be potential targets for understanding and improving the immune response to rubella vaccination or for designing new vaccines that induce more durable immunity.
AuthorsStephen N Crooke, Inna G Ovsyannikova, Richard B Kennedy, Nathaniel D Warner, Gregory A Poland
JournalVaccine (Vaccine) Vol. 38 Issue 50 Pg. 7897-7904 (11 25 2020) ISSN: 1873-2518 [Electronic] Netherlands
PMID33158591 (Publication Type: Journal Article, Research Support, N.I.H., Extramural)
CopyrightCopyright © 2020 Elsevier Ltd. All rights reserved.
Chemical References
  • Chemokines
  • Cytokines
  • Measles-Mumps-Rubella Vaccine
Topics
  • Adult
  • Chemokines (immunology, metabolism)
  • Cytokines (immunology, metabolism)
  • Female
  • Humans
  • Immunity, Cellular
  • Immunity, Humoral
  • Immunization Schedule
  • Leukocytes, Mononuclear (immunology, metabolism)
  • Measles-Mumps-Rubella Vaccine (administration & dosage, immunology)
  • Middle Aged
  • Rubella (immunology, prevention & control)
  • Young Adult

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: